Also planned is a new R&D pilot plant that will produce medicines for clinical trials, said GSK, adding that the programme will "establish Marietta as an innovation and manufacturing hub capable ...
Hosted on MSN1mon
UK M&A activity down in January amid uncertain US opportunitiesThe deal follows GSK’s decision to pump $800m into a new vaccines drug substance facility and R&D pilot plant in the US, with the planned investment set to double the size of the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback